Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 73.64
-0.51 (-0.69%)
At close: Apr 21, 2026
Sino Biological,Inc. Revenue
In the year 2025, Sino Biological,Inc. had annual revenue of 699.56M CNY with 14.00% growth. Sino Biological,Inc. had revenue of 188.12M in the quarter ending December 31, 2025, with 26.49% growth.
Revenue
699.56M
Revenue Growth
+14.00%
P/S Ratio
12.80
Revenue / Employee
685.18K
Employees
1,021
Market Cap
8.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 699.56M | 85.89M | 14.00% |
| Dec 31, 2024 | 613.67M | -32.72M | -5.06% |
| Dec 31, 2023 | 646.39M | 71.79M | 12.49% |
| Jan 1, 2023 | 574.60M | -390.67M | -40.47% |
| Jan 1, 2022 | 965.27M | -631.02M | -39.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Youcare Pharmaceutical Group | 2.45B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 2.06B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.94B |
| Liaoning Chengda Biotechnology | 1.39B |
| Jiangxi Fushine Pharmaceutical | 1.18B |
| Shanghai Medicilon | 1.08B |
| Bio-Thera Solutions | 933.69M |
| Acrobiosystems | 794.52M |